Literature DB >> 7448107

Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.

N Buchanan, M Davis, M Danhof, D D Breimer.   

Abstract

1. The plasma elimination rate of antipyrine and the urinary excretion of antipyrine and its primary metabolites 4-hydroxy-antipyrine, norantipyrine, 3-hydroxymethyl-antipyrine and 3-carboxyantipyrine were measured in five children in the acute phase of malnutrition and after recovery. The results were compared with those obtained in 3 normal children. 2. Upon nutritional rehabilitation antipyrine clearance increased from 0.65 +/- 0.14 ml min-1 kg-1 to 1.07 +/- 0.20 ml min-1 kg-1. 3. The urinary excretion of 4-hydroxy-antipyrine increased from 6.1 +/- 4.5 to 14.7 +/- 5.9%, norantipyrine from 8.8 +/- 5.7 to 14.3 +/- 5.4 and 3-hydroxy-methyl-antipyrine from 11.8 +/- 8.3 to 20.5 +/- 5.6% (% of dose/24h urine). Excretion of unchanged antipyrine decreased from 5.2 +/- 3.7 to 2.7 +/- 0.9% dose. The metabolite profile (ratio between the amounts of the various metabolites excreted) was not significantly different. 4. It is concluded that malnutrition decreases the rate of antipyrine metabolism, but it does not affect the three oxidative pathways differently.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7448107      PMCID: PMC1430089          DOI: 10.1111/j.1365-2125.1980.tb01772.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Location of functional groups in antipyrine metabolites by mass spectrometry.

Authors:  E Zietz; G Spiteller
Journal:  Biomed Mass Spectrom       Date:  1977-06

2.  Pharmacokinetic study of antipyrine in malnourished children.

Authors:  R K Narang; S Mehta; V S Mathur
Journal:  Am J Clin Nutr       Date:  1977-12       Impact factor: 7.045

3.  Genetic control of dicumarol levels in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

4.  Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.

Authors:  M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

Review 5.  Role of nutrition in the drug-metabolizing enzyme system.

Authors:  T C Campbell; J R Hayes
Journal:  Pharmacol Rev       Date:  1974-09       Impact factor: 25.468

6.  Interindividual differences in drug oxidation: clinical importance.

Authors:  F Sjöqvist; C von Bahr
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

7.  Norphenazone, a new metabolite of phenazone in human urine.

Authors:  J D Baty; D A Evans
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

8.  Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.

Authors:  N Buchanan; C Eyberg; M D Davis
Journal:  Am J Clin Nutr       Date:  1979-12       Impact factor: 7.045

9.  Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.

Authors:  K Krishnaswamy; A N Naidu
Journal:  Br Med J       Date:  1977-02-26

10.  Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.

Authors:  M Danhof; E de Groot-van der Vis; D D Breimer
Journal:  Pharmacology       Date:  1979       Impact factor: 2.547

View more
  8 in total

1.  Pharmacokinetics of theophylline in Ethiopian children of differing nutritional status.

Authors:  M Eriksson; L Paalzow; P Bolme; T W Mariam
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.

Authors:  M W Teunissen; G J Bruining; B M De Jongh; E W Tenkate-Westerhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

3.  Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.

Authors:  K Krishnaswamy; R Kalamegham; N A Naidu
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

Review 4.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

5.  Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status.

Authors:  M Eriksson; L Paalzow; P Bolme; T W Mariam
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Chloroquine kinetics in the undernourished.

Authors:  A Tulpule; K Krishnaswamy
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  Drug metabolism and pharmacokinetics in malnourished children.

Authors:  K Krishnaswamy
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 8.  The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies.

Authors:  Meysam Zarezadeh; Ahmad Saedisomeolia; Mahoor Shekarabi; Masoud Khorshidi; Mohammad Reza Emami; Daniel J Müller
Journal:  Eur J Nutr       Date:  2020-11-03       Impact factor: 5.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.